RetBul Revenue
Medical Equipment Manufacturing • 
Ramat Yishai, North District, Israel • 1-10 Employees
$
RetBul revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at RetBul
Yishay Falick
Co-founder & Chief Executive Officer
Company overview
| Headquarters | Ramat Yishai, North District, Israel |
| NAICS | 3391 |
| Keywords | Retina, Opthalmology, Genetherapy, Stemcelltherapy, Retinalphysician, Retinasurgery, Scleral Crosslinking, Subretinal Injection |
| Founded | 2020 |
| Employees | 1-10 |
About RetBul
Retbul developed the only Posterior Eyeball Platform (PEP) for a minimally invasive, reliable, endoscopic approach providing a safe conduit for guiding sophisticated medical equipment to locations behind the globe.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
RetBul has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
RetBul has never raised funding before.
Australia
Hong Kong
United States
Frequently asked questions
RetBul is located in Ramat Yishai, North District, IL.
RetBul generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
RetBul has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
RetBul was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.
RetBul has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
